Trials / Completed
CompletedNCT02945735
Gaze Contingent Feedback in Major Depressive Disorder (MDD)
Gaze Contingent Feedback in Major Depressive Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Tel Aviv University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of Major Depressive Disorder (MDD)
Detailed description
The study examines giving depressive participants gaze-contingent feedback as a novel attention training procedure. Half of the participants will receive contingent feedback while the other half would receive non-contingent "placebo" feedback.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Attention Modification | Feedback according to participants' viewing patterns, in order to modify their attention. |
Timeline
- Start date
- 2016-11-06
- Primary completion
- 2019-01-07
- Completion
- 2019-01-07
- First posted
- 2016-10-26
- Last updated
- 2019-12-18
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02945735. Inclusion in this directory is not an endorsement.